Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Epirus Biopharmaceuticals Inc    EPRSQ

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
06/19/2017 06/20/2017 06/21/2017 06/22/2017 06/23/2017 Date
0.019(c) 0.0131(c) 0(c) 0.0151(c) 0.0189(c) Last
3 621 14 296 92 62 752 626 303 Volume
+46.15% -31.05% -100.00% +25.17% Change
More quotes
Company
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on building a pure-play, sustainable and profitable biosimilar business.It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference... 
More about the company
Latest news on EPIRUS BIOPHARMACEUTICALS
2016 EPIRUS BIOPHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Co..
2016 EPIRUS BIOPHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Te..
2016 EPIRUS Announces Reprioritization of Pipeline to Solely Focus on Biosimilars ..
2016 EPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financi..
2016 EPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Fina..
2016 EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase 3 Clinical Study for..
2016 EPIRUS Biopharmaceuticals to Participate in Bloomberg Intelligence Healthcare..
2016DJJ&J, AbbVie Shares Drop on Potential Drug Competition
2016 EPIRUS Biopharmaceuticals to Present at LEERINK Partners 5th Annual Global He..
2015 EPIRUS Biopharmaceuticals Provides Clinical Program Update on BOW015 (Inflixi..
More news
Sector news : Biotechnology & Medical Research - NEC
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart EPIRUS BIOPHARMACEUTICALS
Duration : Period :
Epirus Biopharmaceuticals  Technical Analysis Chart | EPRSQ | US29428P1075 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Sector and Competitors
1st jan.Capitalization (M$)
EPIRUS BIOPHARMACEUTIC..-33.68%0
INCYTE CORPORATION35.91%27 907
QUINTILES IMS HOLDINGS..19.50%19 657
LONZA GROUP27.12%16 010
CELLTRION, INC.--.--%12 252
ALKERMES PLC5.58%8 957
More Results